AI in Pharmaceuticals and Its Role in Transforming Drug Development

Employers

Discover Talent Today

A close up on a person's hand wearing gloves working on a tablet.

Businesses all over the globe are improving their operations using artificial intelligence. Using this technology, you can process your tasks easier and faster. What’s more impressive is that you can accomplish more with the correct tools than doing things manually.

Aside from revenue and operations benefits, technology has the potential to even improve a person’s life. By implementing AI in pharmaceuticals, it can aid in developing drugs, medicine, and treatment.

 

Shifts in the Industry

Like other industries, healthcare is undergoing a significant transformation. Thanks to modern technology, complicated procedures that needed a lot of financial support are now easier to accomplish. Many tools are being used to improve accessibility for people with diverse needs and backgrounds.

While these benefit patients, they can also lead to intense competition within the industry. Companies that are more knowledgeable and equipped will no doubt become more successful. This requires leaders to stay on top of the latest technology and trends.

For example, the rise of digital therapeutics requires basic knowledge about software-based interventions. It’s also ideal to understand technological accessories. Tools like mobile applications and wearable devices can help prevent patient illnesses.

As generative AI and machine learning continue to gain popularity, you need to find ways to use them to improve your services. This can only be possible if you start by understanding AI and its impact on your industry.

Read More: 10 Ways Technology is Modernizing Health and Human Services

 

AI in Pharmaceuticals

Among all branches of medicine, the pharmaceutical industry is under a lot of pressure to keep up with technological advancements. This requires your company to learn how to embrace cutting-edge technologies to maintain your competitive advantage.

The adoption of AI solutions in pharmaceuticals is growing.¹ Pharma industry leaders are trying to enhance their research and drug development with AI-driven innovations. Patents in automated cell positioning and predictive modeling are proof of their dedication to creating results using AI.

Major industry players are also actively forming partnerships and acquiring AI startups. They’re investing in AI-driven solutions that would be useful to their operations. When implemented safely, these can help companies gain the upper hand. As part of the industry, your company needs to take this as a sign to begin doing the same. Here’s how:

 

1. Drug Discovery

Discovering new drugs can be difficult and time-consuming. It usually needs financial support in research and development. From laboratory experiments to analyzing existing drugs, drug discovery needs effort to become successful.

Luckily, AI solutions like machine learning can help make this process easier. AI systems can analyze vast amounts of data, including genetic information and molecular structures. This makes it easier for professionals to identify potential drug candidates efficiently.

Once potential drugs are found, AI can also assist in the virtual screening of chemical compounds. This makes it easier to predict the effectiveness of the medicine by observing its interactions with the biological targets.

 

2. Clinical Trials

If drug discovery takes a lot of time, clinical trials require even more. Since this step requires the appropriate clinical candidates, companies become responsible for locating, analyzing, and managing candidate data. This becomes difficult in cases when a lot of people are needed for the test.

With the power of AI, professionals can collect and analyze vast amounts of data quickly. It’s also easier to understand which patients are the most suitable for clinical trials.

Aside from pre-trials, artificial intelligence can also improve the process and outcomes of your tests. This includes optimizing your clinical trial designs and predicting potential challenges that could lead to poor results.

 

3. Precision Medicine

When people think of technology, they think of machines in general, but this isn’t always the case. In the pharmaceutical industry, AI can offer customized treatment plans and suggestions based on a patient’s characteristics, genetic makeup, and potential health risks.

Since technology can organize and store data quickly, clinicians can use AI to create unique profiles for their patients. These profiles can include specific information about their details, medical history, and other vital data. Artificial intelligence at this stage can maximize efficiency while minimizing the side effects of personalized treatments.

 

4. Biomarker Discovery

Another excellent basis for prescriptions is a person’s biomarkers. Despite their importance, biomarkers can be challenging to identify. This is where AI solutions become useful.

Using various AI techniques like deep learning and natural language processing, experts can identify biomarkers using technology to analyze large datasets. Medical imaging, patient history, and electronic health records could contribute to identifying a person’s biomarkers. This can then increase the potential for early disease detection and effective monitoring for treatment response.

 

5. Drug Repurposing

Experts in the pharmaceutical industry do more than drug discovery processes. They also focus on repurposing existing drugs. This involves finding new therapeutic applications for medicines that are already available on the market.

With so many drugs available, it can be challenging to keep track of each progress. Fortunately, AI tools can be used to manage huge data sets without a hassle. By effectively analyzing drug information, AI algorithms can identify medicines and treatments for repurposing. This reduces the time and cost associated with making new medicines from scratch.

 

6. Vaccine Design

Pharma companies tend to spend a lot of their time on drug development because of the complexity of designing vaccines. So, to decrease effort while improving effectiveness, professionals can consider using artificial intelligence.

AI algorithms can predict antigen structures, which is crucial for vaccine design. It can also be programmed to stimulate the immune response of patients, giving experts valuable insights into how their designs can affect their patients.

 

7. Pharmacovigilance

Once drug development and dissemination are finished, experts undergo the pharmacovigilance process.² In simple terms, this is the practice of monitoring the effects of medical drugs after being licensed for use. It is meant to evaluate the effectiveness of the medicine in the actual market while keeping an eye out for unreported adverse reactions.

AI plays a crucial role in this step since its IT solutions can give professionals access to data. It can be programmed to analyze clinical reports and social media trends about the new drug.

Moreover, AI’s machine learning capabilities can detect patterns and trends that the human eye can have difficulty seeing. This enables more proactive monitoring and better risk mitigation strategies.

 

STAY COMPETITIVE IN YOUR INDUSTRY WITH STRATEGIC SYSTEMS

To gain a competitive edge in your industry, you need to have the right people to support you. Here at Strategic Systems, we believe that partnerships define success. We want to empower you with excellent people and tailored solutions specific to your needs.

No matter the challenge you’re encountering, we are confident that we have the solution for you. Benefit from our nearly two decades of experience and find ways for you to strive within your field.

Reach out to us today to start a conversation.

 

References

  1. “Revealed: Pharmaceutical Companies Leading the Way in Artificial Intelligence.” Clinical Trials, 26 Jun. 2022, www.clinicaltrialsarena.com/features/revealed-pharmaceutical-companies-leading-the-way-in-artificial-intelligence/?cf-view.
  2. “Pharmacovigilance.” European Commission’s Health and Food Safety Directorate-General, health.ec.europa.eu/medicinal-products/pharmacovigilance_en. 26 Apr. 2024.